• Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

  • Sep 12 2024
  • Length: 2 hrs and 3 mins
  • Podcast

Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

  • Summary

  • Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates on available and emerging treatment strategies for non-small cell lung cancer with an EGFR mutation.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.